COVID-19 pandemic
E67147
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
Aliases (9)
- COVID-19 ×3
- COVID-19 pandemic in the United States ×3
- COVID-19 pandemic in Canada ×1
- COVID-19 pandemic in the UK ×1
- COVID-19 pandemic response in England ×1
- COVID-19 pandemic response in Massachusetts ×1
- COVID-19 pandemic response in New Hampshire ×1
- COVID-19 pandemic response in Wisconsin ×1
- COVID‑19 pandemic ×1
Statements (73)
| Predicate | Object |
|---|---|
| instanceOf |
global health crisis
→
pandemic → |
| affects |
global population
→
|
| cause |
COVID-19
→
|
| declarationAsPandemicDate |
2020-03-11
→
|
| declarationAsPublicHealthEmergencyOfInternationalConcernDate |
2020-01-30
→
|
| declaredBy |
World Health Organization
→
|
| economicImpact |
global recession
→
increased unemployment → supply chain disruptions → |
| hasCauseAgent |
SARS-CoV-2
→
|
| hasSymptom |
cough
→
fatigue → fever → loss of smell → loss of taste → shortness of breath → |
| hasVaccine |
inactivated virus COVID-19 vaccines
→
mRNA COVID-19 vaccines → protein subunit COVID-19 vaccines → viral vector COVID-19 vaccines → |
| ledTo |
development of mRNA vaccine platforms
→
emergency use authorization of vaccines → global mask mandates in many regions → increased investment in public health infrastructure → travel health certificates and vaccine passports → |
| majorVaccineDeveloper |
AstraZeneca
→
Gamaleya Research Institute → Johnson & Johnson → Moderna → Pfizer–BioNTech → Sinopharm → Sinovac → |
| monitoredBy |
Centers for Disease Control and Prevention
→
World Health Organization → national public health agencies → |
| notableVariant |
Alpha variant
→
Beta variant → Delta variant → Gamma variant → Omicron variant → |
| preventiveMeasure |
face masks
→
hand hygiene → isolation of cases → lockdowns → physical distancing → quarantine → remote work policies → school closures → travel restrictions → vaccination → |
| publicHealthResponse |
contact tracing
→
genomic surveillance of variants → mass testing → |
| relatedTo |
2019–2020 coronavirus outbreak in China
→
global vaccination campaigns → |
| riskFactor |
crowded indoor environments
→
immunosuppression → older age → underlying health conditions → |
| socialImpact |
border closures
→
cancellation of public events → mental health challenges → rise of remote learning → rise of telemedicine → school closures worldwide → travel bans → |
| startLocation |
Wuhan, Hubei, China
→
|
| startTime |
2019-12
→
|
| transmissionMethod |
aerosols
→
close contact → contaminated surfaces → respiratory droplets → |